Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Compare UK pharmaceutical companies and biotech shares. See a comparison of key indicators, including pharma stock price targets and analyst recommendations.
Comparison Results
Name | Price | Price Change | Analyst Price Target | Analyst Consensus | Volume | Market Cap | Smart Score | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|
AstraZeneca | 10206.00p | 119p (1.18%) | 12,840.00p (25.81% Upside) | 10 Buy 2 Hold 0 Sell Strong Buy | 182.52K | £156.94B | premium | ||
GlaxoSmithKline | 1435.60p | 14.4p (1.01%) | 1,519.13p (5.82% Upside) | 3 Buy 4 Hold 3 Sell Hold | 406.99K | £57.79B | premium | ||
Hikma Pharmaceuticals | 1761.50p | 42.5p (2.47%) | 2,030.00p (15.24% Upside) | 2 Buy 3 Hold 0 Sell Moderate Buy | 51.94K | £3.81B | premium | ||
HUTCHMED (China) Limited | 290.00p | 15p (-4.92%) | 870.95p (200.33% Upside) | 2 Buy 1 Hold 0 Sell Moderate Buy | 55.07K | £2.65B | premium | ||
Dechra Pharmaceuticals | 3826.00p | 1p (0.03%) | ― | ― | 63.92K | £4.36B | premium |
Performance Comparison
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.
Pharma & Biotech Stocks Latest News
Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Pharma & Biotech Stocks
GlaxoSmithKline
premium
premium
Sell
premium
premium
Reiterated
AstraZeneca
premium
premium
Buy
premium
premium
Reiterated
Hikma Pharmaceuticals
premium
premium
Hold
premium
premium
Reiterated
HUTCHMED (China) Limited
premium
premium
Hold
premium
premium
Reiterated
Dechra Pharmaceuticals
premium
premium
Hold
premium
premium
Downgraded
GlaxoSmithKline
premium
premium
Sell
premium
premium
Reiterated
GlaxoSmithKline
premium
premium
Buy
premium
premium
Reiterated
GlaxoSmithKline
premium
premium
Hold
premium
premium
Reiterated
GlaxoSmithKline
premium
premium
Buy
premium
premium
Reiterated
GlaxoSmithKline
premium
premium
Hold
premium
premium
Assigned
Most Recent Earnings of Pharma & Biotech Stocks
AstraZeneca
Nov 09, 2023
Sep 01, 2023
131.983
GlaxoSmithKline
Nov 01, 2023
Sep 01, 2023
46.9
Hikma Pharmaceuticals
Aug 03, 2023
Jun 01, 2023
72.097
HUTCHMED (China) Limited
Jul 31, 2023
Jun 01, 2023
-14.962
Dechra Pharmaceuticals
Oct 12, 2023
Jun 01, 2023
16.1
Pharma & Biotech Stocks - FAQ
Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
AstraZeneca - Strong Buy, based on 12 analyst ratings, 10 Buy, 2 Hold, and 0 Sell.
Are Pharma & Biotech stocks overpriced?
AstraZeneca's stock price is currently 10,206.00p, and its average 12-month price target is 12,840.00p.
GlaxoSmithKline's stock price is currently 1,435.60p, and its average 12-month price target is 1,519.13p.
Hikma Pharmaceuticals's stock price is currently 1,761.50p, and its average 12-month price target is 2,030.00p.
HUTCHMED (China) Limited's stock price is currently 290.00p, and its average 12-month price target is 870.95p.
Dechra Pharmaceuticals's stock price is currently 3,826.00p, and its average 12-month price target is N/A.
Which Pharma & Biotech stocks pay dividends?
AstraZeneca does not currently pay dividends.
GlaxoSmithKline does not currently pay dividends.
Hikma Pharmaceuticals does not currently pay dividends.
HUTCHMED (China) Limited does not currently pay dividends.
Dechra Pharmaceuticals does not currently pay dividends.
Popular Stocks Comparisons
Latest News
Pharma & Biotech Stock Events
Stock | Type | Date |
|---|---|---|
GlaxoSmithKline | Earnings Release | Jan 31, 2024 |
AstraZeneca | Earnings Release | Feb 08, 2024 |
Hikma Pharmaceuticals | Earnings Release | Feb 22, 2024 |
Dechra Pharmaceuticals | Earnings Release | Feb 26, 2024 |
HUTCHMED (China) Limited | Earnings Release | Feb 29, 2024 |